Just 22% of Medicare Part D plans achieved robust generic drug substitution rates for very high cost drugs in an analysis of 2017 plans conducted by Avalere for the Association for Accessible Medicines.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?